Shanghai-based BVCF, a growth capital-focused private equity fund specializing in the life sciences industry, has completed a final close of its third fund, raising a total of US$200 million, according to media reports.
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Read 2 Articles for Free with a Basic Account
Gain limited and restricted access to China Money Network.Register Basic Account
Subscribe for an annual subscription!
Enjoy comprehensive and exclusive data you can't find elsewhere!More Info
Already have an account or paid subscription?